Medication adherence improves value-based care outcomes and is increasingly the most important focus to achieve incentives. With endless “white noise” that creates inefficiencies in practice patterns, providers seek streamlined turnkey solutions that integrate into the workflow.
For more than a decade, AdhereHealth has helped providers address medication-focused P4P programs sponsored by managed care or government entities. Overcoming consumer social determinants is an important factor to advance quality measurement goals. These complex quality measurement systems require sophisticated technologies that engage consumers and their providers to close care gaps.
Adhere™ is AdhereHealth’s medication-focused platform of integrated solutions, with analytics that stratify consumer populations, prioritize interventions and resolve gaps in care to achieve value-based care outcomes.
With AdhereHealth’s Pharmacy at Home™ solutions, consumers can receive medications in the comfort of their home. Pharmacy at Home™ includes real-time medication synchronization with AdhereHealth’s pharmacy solution partners. Included in these consumer options is AdhereHealth’s digital pharmacy, AdhereRx™, which provides hand-delivered pharmacy right to the home for high-acuity consumers who benefit from ongoing medication counseling for polypharmacy management.
Adhere™ integrates high-acuity analytics into its high-touch pharmacy, AdhereRx™, to support consumers who would benefit from ongoing medication counseling and hand-delivered pharmacy. With a complex value-based care system and challenging populations, it is critical to partner with companies that fully align on shared risk.
The Adhere™ platform includes Stratify™ analytics, powered by QiLink™ clinical workflow. This platform includes powerful analytics, a nationwide licensed clinical network and real-time medication synchronization for partner pharmacies that deliver to the consumer’s home. Adhere’s performance-based alignment with providers guarantees each consumer measurement conversion.